Anileridine

CHEMBL1201347 Phase 4 ได้รับการอนุมัติ Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

352.5 g/mol

LogP

3.7

Phase

4

An opioid analgesic that binds to mu-opioid receptors in the brain and spinal cord to relieve moderate to severe pain. Like other opioids, it carries risks of respiratory depression, dependence, and tolerance.

น้ำหนักโมเลกุล

352.5000 g/mol

LogP

3.70

TPSA

55.60 Å²

Lipinski RO5

ผ่าน

กลไกการออกฤทธิ์

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

กลไก

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission …

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure

Embed this structure

SMILES

CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1

InChI

InChI=1S/C22H28N2O2/c1-2-26-21(25)22(19-6-4-3-5-7-19)13-16-24(17-14-22)15-12-18-8-10-20(23)11-9-18/h3-11H,2,12-17,23H2,1H3

Molecular Formula

C22H28N2O2

HBD / HBA

1 / 4

พันธะที่หมุนได้

7

อะตอมหนัก

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

An opioid analgesic that binds to mu-opioid receptors in the brain and spinal cord to relieve moderate to severe pain. Like other opioids, it carries risks of respiratory depression, dependence, and tolerance.

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.

Yes, Anileridine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201347. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 8944. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

กำลังมองหาข้อมูลที่เข้าใจง่ายสำหรับผู้ป่วยอยู่ใช่ไหม?

Anileridine บน PillFYI

โครงสร้าง

ข้อมูลด่วน

สูตร: C22H28N2O2

ลิงก์ภายนอก

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.